Smart Syringes Market by Theraupetics, Application, End User

List of Tables

[188 Pages Report] The Smart Syringes Market size was estimated at USD 8.44 billion in 2023 and expected to reach USD 10.46 billion in 2024, at a CAGR 24.61% to reach USD 39.38 billion by 2030.

Smart syringes are a remarkable innovation in medical devices, specifically designed to improve safety and efficiency in the administration of medications. These advanced syringes have features such as auto-disable mechanisms, which prevent reuse, and needlestick injury prevention safeguards. By incorporating technology that ensures a single use, smart syringes significantly reduce the transmission of blood-borne diseases, including HIV, hepatitis B, and hepatitis C, that can occur through needle reuse or improper disposal. The enhanced awareness about needlestick injuries and the spread of infectious diseases led to a higher need for smart syringes. Government policies and initiatives are promoting using smart syringes for injections and immunizations. However, the advanced features of smart syringes result in higher costs than traditional syringes, which may limit adoption in low-income countries. In addition, the strict government norms and associated product recalls for smart syringes further limit their penetration worldwide. Nevertheless, the ongoing efforts to develop smart syringes that can communicate with digital health records to track and manage vaccinations and drug delivery are expanding the scope of the smart syringes market. Moreover, increasing healthcare expenditures and advancing applicability are anticipated to drive the usage of smart syringes in the coming years.

KEY MARKET STATISTICS
Base Year [2023]	USD 8.44 billion
Estimated Year [2024]	USD 10.46 billion
Forecast Year [2030]	USD 39.38 billion
CAGR (%)	24.61%

Therapeutics: Increasing use of auto-disable syringes for immunization campaigns

Active safety syringes require manual safety feature activation to prevent needlestick injuries. Active safety syringes are preferred in situations demanding the professional's control over the safety mechanism, often used by trained healthcare personnel in hospitals. Active safety syringes are ideal for controlled environments where training on usage is provided, ensuring safety protocols are actively followed. Auto-disable syringes are designed to prevent reuse by automatically disabling the syringe after a single use. Auto-disable syringes are suitable for immunization campaigns and in settings with high risks of infectious disease transmission through syringe reuse. Passive safety syringes have built-in safety mechanisms that automatically engage to protect users from needlestick injuries, requiring no active input from the user. Passive safety syringes are favored in fast-paced environments, where immediate attention to safety features is beneficial. Passive safety syringes are ideal for emergency departments and clinics where quick administration of injections is common, enhancing safety without disrupting workflow.

Application: Wide applicability of smart syringes for drug delivery

The application of smart syringes in blood specimen collection is primarily geared towards enhancing safety and accuracy. These syringes prevent needle-stick injuries and ensure precise volume collection, significantly reducing the risk of cross-contamination. Smart syringes for drug delivery play a critical role in chronic disease management, including diabetes and autoimmune diseases. These syringes ensure precise dosage, minimize wastage, and enhance patient compliance with treatment schedules. The deployment of smart syringes in vaccination programs is paramount to global health initiatives, ensuring safe, efficient, and equitable distribution and administration of vaccines. These devices are instrumental in reducing vaccine waste and ensuring the correct dose delivery. Blood specimen collection focuses on safety and precision, whereas drug delivery emphasizes dosage accuracy and patient compliance. Vaccination smart syringes aim to optimize vaccine utilization and global health outcomes.

Regional Insights

The Americas represent a highly developing smart syringes market, attributed to strong healthcare regulations, advanced medical technology, and high awareness among healthcare professionals. Investment in research and the patent landscape is dynamic in the Americas, reflecting a robust innovation ecosystem. Europe, the Middle East, and Africa observe highly evolving smart syringes due to stringent healthcare regulations, high-quality healthcare systems, and increased awareness of advanced healthcare solutions. The region shows promise with growing awareness and government initiatives to improve healthcare standards. The Asia-Pacific region is rapidly emerging as a significant market for smart syringes, driven by substantial healthcare sector investments, government initiatives for infectious disease control, and the increasing adoption of advanced medical technologies. Regional focus on domestic innovation has also seen a rise in patents related to smart syringes. Asia-Pacific represents a vast potential for the smart syringes market due to its large population, increasing healthcare expenditure, and growing awareness of healthcare practices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Smart Syringes Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Smart Syringes Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Smart Syringes Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Agilent Technologies, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Biocorp by Novo Nordisk A/S, Cardinal Health, Inc., DMC Medical Limited, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Medtronic PLC, MHC Medical Products, LLC, Numedico Technologies Pty Ltd., Owen Mumford Limited, Parker-Hannifin Corporation, Retractable Technologies, Inc., Revolutions Medical Corporation, Shanghai Kohope Medical Co., Ltd., Sharps Technology, Inc., Shimadzu Corporation, Smiths Group PLC, Sol-Millennium Medical Group, Stevanato Group, Tecan Group Ltd., Terumo Corporation, Thermo Fisher Scientific Inc., UltiMed, Inc., and Vogt Medical Vertrieb GmbH.

Market Segmentation & Coverage

This research report categorizes the Smart Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

Theraupetics
- Active Safety Syringes
- Auto-disable Syringes
- Passive Safety Syringes

Application
- Blood Specimen Collection
- Drug Delivery
- Vaccination

End User
- Diagnostics Center
- Hospitals & HMOs
- Physician Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Smart Syringes Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Smart Syringes Market?

3. What are the technology trends and regulatory frameworks in the Smart Syringes Market?

4. What is the market share of the leading vendors in the Smart Syringes Market?

5. Which modes and strategic moves are suitable for entering the Smart Syringes Market?

Product Code: MRR-03050D1B2D40

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
  - 5.1.1.2. Increasing Number of Vaccination Campaigns and Initiatives
  - 5.1.1.3. Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
- 5.1.2. Restraints
  - 5.1.2.1. Smart Syringes Product Recalls
- 5.1.3. Opportunities
  - 5.1.3.1. Growing Need for Environmentally Safe and Auto Disable Syringes
  - 5.1.3.2. Stringent Regulation for Patient Health and Safety
- 5.1.4. Challenges
  - 5.1.4.1. Low Awareness and Usage of Smart Syringes in Developing Countries
5.2. Market Segmentation Analysis
- 5.2.1. Therapeutics: Increasing use of auto-disable syringes for immunization campaigns
- 5.2.2. Application: Wide applicability of smart syringes for drug delivery
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis

6. Smart Syringes Market, by Theraupetics

6.1. Introduction
6.2. Active Safety Syringes
6.3. Auto-disable Syringes
6.4. Passive Safety Syringes

7. Smart Syringes Market, by Application

7.1. Introduction
7.2. Blood Specimen Collection
7.3. Drug Delivery
7.4. Vaccination

8. Smart Syringes Market, by End User

8.1. Introduction
8.2. Diagnostics Center
8.3. Hospitals & HMOs
8.4. Physician Clinics

9. Americas Smart Syringes Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Smart Syringes Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Smart Syringes Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections
- 12.3.2. Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over USD 400 Million from Nephron Pharmaceuticals
- 12.3.3. Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio